Details of the Drug

General Information of Drug (ID: DM8U4UJ)

• Drug Name: Muscular dystrophy gene therapy

Indication

Disease Entry	ICD 11	Status	REF
Duchenne dystrophy	8C70	Phase 1	[1]

• Cross-matching ID: TTD ID: D0C8JW

References

• [1] Clinical pipeline report, company report or official report of Asklepios BioPharmaceutical.